IL-6 has been reported, by Zhang et al. in a study in 2022, to facilitate chemoresistance in acute myelocytic leukemia (AML) through the uptake of FAs, regulated by stat3/CD36FA uptake [109]. The gene discussed is IL6; the disease is acute myeloid leukemia.